Policlinique Médicale Universitaire   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Lausanne Switzerland

Organization Overview

First Clinical Trial
2000
NCT00322907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Policlinique Médicale Universitaire

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Glucose Metabolism Disorders (Phase 4)

Hemorrhagic Fever, Ebola (Phase 2)

Malaria (Phase 2)

Metabolic Diseases (Phase 4)

Metabolic Side Effects of Drugs and Substances (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 8